Related Experiment Video
Updated: Jul 18, 2026

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)
Published on: June 15, 2018
c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function
R C Ishizawar1, T Miyake, S J Parsons
1Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, VA 22908, USA.
The study reveals that c-Src kinase enhances the interaction between ErbB2 and ErbB3 receptors, boosting breast cancer cell growth and motility. Inhibiting c-Src disrupts this oncogenic signaling pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Overexpression of c-Src and epidermal growth factor receptor (EGFR/ErbB) family members is linked to breast cancer development.
- EGFR/ErbB family members form heterocomplexes, and c-Src physically interacts with them in breast cancer.
- The ErbB2/ErbB3 heterocomplex exhibits significant oncogenic potential.
Purpose of the Study:
- To investigate the role of c-Src in modulating the physical and functional interaction between ErbB2 and ErbB3.
- To determine if c-Src acts upstream or downstream of ErbB2/ErbB3 signaling.
- To elucidate the impact of c-Src on the oncogenic functions mediated by the ErbB2/ErbB3 heterocomplex.
Main Methods:
- Overexpression of wild-type and kinase-inactive c-Src (K(-) c-Src) in breast cancer cells.
- Pharmacological inhibition of c-Src using PP2.
- Assessment of ErbB2/ErbB3 heterocomplex formation and receptor activation.
- Evaluation of downstream signaling pathways and cellular functions like motility and anchorage-independent growth.
Main Results:
- Overexpressed wild-type c-Src enhances ErbB2/ErbB3 heterocomplex formation.
- This enhancement leads to increased basal and heregulin-induced activation of ErbB2/ErbB3 and downstream effectors.
- Inhibition or inactivation of c-Src abrogates ErbB2/ErbB3-mediated cellular motility and anchorage-independent growth.
- c-Src positively modulates ErbB2/ErbB3 association, suggesting an upstream role.
Conclusions:
- c-Src plays a critical upstream role in enhancing ErbB2/ErbB3 signaling and oncogenic functions in breast cancer.
- Modulation of ErbB2/ErbB3 association by c-Src is a key mechanism driving tumor progression.
- Targeting c-Src may represent a therapeutic strategy for breast cancers driven by ErbB2/ErbB3 signaling.
Related Concept Videos
Mitogens and the Cell Cycle
MAPK Signaling Cascades
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

